Anti-tumor necrosis factor alpha treatment with adalimumab improves significantly endothelial function and decreases inflammatory process in patients with chronic psoriasis

被引：47
作者：
Avgerinou, Georgia [2 ]
Tousoulis, Dimitris [1 ]
Siasos, Gerasimos [1 ]
Oikonomou, Evaggelos [1 ]
Maniatis, Konstantinos [1 ]
Papageorgiou, Nikolaos [1 ]
Paraskevopoulos, Theodoros [1 ]
Miliou, Antigoni [1 ]
Koumaki, Dimitra [2 ]
Latsios, George [1 ]
Therianiou, Anastasia [1 ,2 ]
Trikas, Athanasios [1 ]
Kampoli, Anna Maria [1 ]
Stefanadis, Christodoulos [1 ]
机构：
[1] Univ Athens, Sch Med, Hippokrat Hosp, Cardiol Unit 1, Athens 11528, Greece
[2] Univ Athens, Dept Dermatol 1, A Sygros Hosp, Athens 11528, Greece
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2011年 / 151卷 / 03期
关键词：
Inflammation; Adalimumab; Psoriasis; Endothelium; REPORTED OUTCOMES; TRIAL; RISK;
D O I：
10.1016/j.ijcard.2011.06.112
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：382 / 383
页数：2
相关论文
共 50 条
  • [21] Risk of tuberculosis with anti-tumor necrosis factor-alpha therapy in patients with psoriasis and psoriatic arthritis in Indian population
    Sarkar, Soumajyoti
    Panda, Saumya
    Kim, Byungsoo
    Raychaudhuri, Smriti K.
    Ghosh, Asutosh
    Raychaudhuri, Siba P.
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2020, 86 (01) : 1 - 7
  • [22] Management of Inflammatory Bowel Disease with Infliximab and Other Anti-Tumor Necrosis Factor Alpha Therapies
    Magro, Fernando
    Portela, Francisco
    BIODRUGS, 2010, 24 : 3 - 14
  • [23] Anti-Tumor Necrosis Factor Alpha Antibodies for Remission Maintenance Therapy in Inflammatory Bowel Disease
    Neubauer, Katarzyna
    Kempinski, Radoslaw
    Poniewierka, Elzbieta
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2010, 19 (02): : 143 - 149
  • [24] Management of Inflammatory Bowel Disease with Infliximab and Other Anti-Tumor Necrosis Factor Alpha Therapies
    Fernando Magro
    Francisco Portela
    BioDrugs, 2010, 24 : 3 - 14
  • [25] Effect of anti-tumor necrosis factor-α therapies on body mass index in patients with psoriasis
    Saraceno, Rosita
    Schipani, Caterina
    Mazzotta, Annamaria
    Esposito, Maria
    Di Renzo, Laura
    De Lorenzo, Antonino
    Chimenti, Sergio
    PHARMACOLOGICAL RESEARCH, 2008, 57 (04) : 290 - 295
  • [26] Relapse rates of inflammatory bowel disease patients in deep and clinical remission after discontinuing anti-tumor necrosis factor alpha therapy
    Hlavaty, T.
    Krajcovicova, A.
    Letkovsky, J.
    Sturdik, I
    Koller, T.
    Toth, J.
    Huorka, M.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2016, 117 (04): : 205 - 211
  • [27] Chronic Ulcer on the Tongue as a Manifestation of Histoplasmosis During Anti-tumor Necrosis Factor-Alpha (TNF-α) Inhibitor Therapy for Psoriasis
    Harrison, Iris
    Forouzandeh, Mahtab
    Motaparthi, Kiran
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [28] Dramatic Response to Ustekinumab Treatment in a Patient with Ankylosing Spondylitis and Crohn's Disease and Anti-tumor Necrosis Factor-alpha Drug Induced Psoriasis
    Kilic, Sevilay
    Resorlu, Hatice
    Ekinci, Alper
    Keskin, Ayse Selcen Bulut
    TURK OSTEOPOROZ DERGISI-TURKISH JOURNAL OF OSTEOPOROSIS, 2020, 26 (03): : 197 - 200
  • [29] Impact of anti-tumor necrosis factor treatment on lipid profiles in Korean patients with ankylosing spondylitis
    Kwon, Inbeom
    Choi, Nayeon
    Shin, Ji Hui
    Lee, Seunghun
    Nam, Bora
    Kim, Tae-Hwan
    JOURNAL OF RHEUMATIC DISEASES, 2024, 31 (01): : 41 - 48
  • [30] Effects of Anti-Tumor Necrosis Factor Therapy on Body Composition and Insulin Sensitivity in Patients With Psoriasis
    Kofoed, Kristian
    Clemmensen, Anders
    Mikkelsen, Ulla R.
    Simonsen, Lene
    Andersen, Ove
    Gniadecki, Robert
    ARCHIVES OF DERMATOLOGY, 2012, 148 (09) : 1089 - 1091
12345